Imidazo[2,1-b]thiazoles: multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases.
Fidanze, S.D., Erickson, S.A., Wang, G.T., Mantei, R., Clark, R.F., Sorensen, B.K., Bamaung, N.Y., Kovar, P., Johnson, E.F., Swinger, K.K., Stewart, K.D., Zhang, Q., Tucker, L.A., Pappano, W.N., Wilsbacher, J.L., Wang, J., Sheppard, G.S., Bell, R.L., Davidsen, S.K., Hubbard, R.D.(2010) Bioorg Med Chem Lett 20: 2452-2455
- PubMed: 20346655 
- DOI: https://doi.org/10.1016/j.bmcl.2010.03.015
- Primary Citation of Related Structures:  
3LZB - PubMed Abstract: 
The design and enzyme activities of a novel class of imidazo[2,1-b]thiazoles is presented.
Organizational Affiliation: 
Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064, USA. steve.fidanze@abbott.com